Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking antipsychotic medication.
Insights April 6, 2021
Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics
J Clin Psychiatry 2020;81(3):OT19037BR3
Vol 86 • 2025 • Number 3
Read the Current Issue
Original Research
Treatment Use and Preference in a Diverse Sample of Women With Mood Disorders
Original Research
Klotho and Matrix Metalloproteinase-9 Levels and Their Association with Inhibitory Dyscontrol in Adolescents with First-Episode Major Affective Disorders
Original Research
Niacin-Induced Response in Early Psychosis
Original Research
Early Ketamine Response Reduces Suicidal Events at 3 Months
Letter to the Editor
Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use
Original Research
Effect of Nature Videos on the Burden of Caregivers of Patients with Dementia
Related Articles
Insights
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
May 17, 2022
Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
